COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma's Annual General Meeting 2024
20/03/2024
Company announcement – No. 17 / 2024 Zealand Pharma's Annual General Meeting 2024 Copenhagen, March 20, 2024 - Today, Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL) (CVR no. 20 04 50 78), held its Annual General Meeting [...]
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
20/03/2024
FORT WORTH, March 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing [...]
DAS Health Expands Presence with New Chicago Office Location
20/03/2024
Chicago, March 20, 2024 (GLOBE NEWSWIRE) -- DAS Health, a nationally recognized leader in providing comprehensive health IT and management solutions exclusively for healthcare clients, is thrilled to announce the grand [...]
SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT AND PROVIDES TRADING UPDATE
20/03/2024
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW [...]
Orion Corporation: Organising meeting of the Board of Directors
20/03/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 MARCH 2024 at 17.00 EET Orion Corporation: Organising meeting of the Board of Directors In its organising [...]
Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
20/03/2024
Seek approval from the FDA for the modification of the Gloperba ® label to include its ability to utilize dosing flexibility of liquid formulation to address unmet medical needs and provide specific dosing guidance to [...]
COVID Origin Is a Gordian Knot, according to the Journal of American Physicians and Surgeons
20/03/2024
TUCSON, Ariz., March 20, 2024 (GLOBE NEWSWIRE) -- Controversy over the origin of the SARS-CoV-2 virus that causes COVID-19—a natural zoonosis vs. a lab leak—has escalated to high-level acrimony and even threatened [...]
Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024
20/03/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 20 MARCH 2024 at 16.50 EET Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024 At the Annual General Meeting of Orion [...]
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
20/03/2024
Novel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: [...]
XTL To Aquire The Social Proxy
20/03/2024
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement RAMAT GAN [...]
Dr. Zeke Unveils Breakthrough Scoliosis Treatment, Transforming Lives in Austin, TX
20/03/2024
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- Dr. Zeke Harkleroad, has specialized in the field of spinal health and scoliosis treatment for over 25 years, is making waves once again with life-changing advancements [...]
Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial
20/03/2024
LOS ANGELES, CA, March 20, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in AL [...]
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
20/03/2024
Presentation highlights Nurix’s innovation and leadership in targeted protein modulation, including ligase inhibition Unique mechanism of action, an intramolecular glue, locks the E3 ligase Casitas B-lineage lymphoma [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
20/03/2024
OCALA, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO [...]
Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
20/03/2024
Company Has Already Received IND Clearance from the FDA and Plans to Begin Phase 1/2 Study in 2024 with Off-the-Shelf, Placental-Derived Cell Therapy FLORHAM PARK, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Celularity Inc [...]
TFF Pharmaceuticals Announces Update on Clinical Programs
20/03/2024
Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potential to Address a Significant Unmet Need in Lung Transplant Medicine and Substantial Market [...]
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
20/03/2024
GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ, Sets Sights on Expansion Into Costa Rica and Central America
20/03/2024
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- via IBN – Eko2o S.A.S., a leader in sustainable agricultural technologies and a majority-owned subsidiary of SFWJ, doing business as MedCana, today announces its [...]
RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
20/03/2024
Glen Rock, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”), focused on the discovery and development of innovative and revolutionary [...]

Pages